We are live on
!
Find out more
ZEAL
Zealand Pharma A/S American Depositary Shares
ZEAL
ZEAL
Delisted
ZEAL was delisted on the 29th of September, 2022.
14 hedge funds and large institutions have $22M invested in Zealand Pharma A/S American Depositary Shares in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
13% less funds holding
Funds holding: 16 → 14 (-2)
44% less capital invested
Capital invested by funds: $39.5M → $22M (-$17.5M)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Holders
14
Holders Change
-2
Holders Change %
-12.5%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
5
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$4.54M |
| 2 |
BlackRock
New York
|
+$33K |
| 3 |
Morgan Stanley
New York
|
+$13.9K |
| 4 |
S
SignatureFD
Atlanta,
Georgia
|
+$5.03K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$3.43K |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$20.4M |
| 2 |
Jane Street
New York
|
-$668K |
| 3 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$370K |
| 4 |
JP Morgan Chase
New York
|
-$26K |
| 5 |
PA
Parallel Advisors
San Francisco,
California
|
-$2K |
